Donald Trump’s nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services (HHS) has caused significant turmoil in the stock market, with major pharmaceutical stocks dropping—Moderna by seven percent, Pfizer by three percent, and Novavax by five percent. Known for his strong stance against vaccines, Kennedy’s appointment has raised concerns among health experts but gained support for his focus on curbing harmful ingredients and promoting healthier lifestyles. As head of HHS, Kennedy would oversee the CDC, FDA, and NIH, giving him the authority to enact his “Make America Healthy Again” initiative. His plan centers on addressing corporate influence, which he argues prioritizes profit over public health, contributing to high healthcare spending and poor health outcomes in the U.S. Continue here.
If you do need a website or your business needs a website, we’re here to bring your dreams to live. Contact us. We would give you the best in quality and the most affordable you would get on the market place. Enjoy our 100% refundable deals. You can’t loose let’s talk about your project.
Kindly reach out on WhatsApp directly and let’s make this decision your most important and best investment post 3 years.
Disclaimer: Full credit to the writer, and the associates.
